News Focus
News Focus
Replies to #72794 on Biotech Values
icon url

corpstrat

02/05/09 3:08 PM

#72796 RE: jbog #72794

It's interesting that Roche's successes are those of a merchant bank's - buying a majority of DNA when it was down on its luck, for example. They do not have a single scientist in their top mgt echelons and zero star scientists on the premises - the bosses are finance and legal guys.
icon url

rkrw

02/05/09 4:15 PM

#72801 RE: jbog #72794

I don't think the 86.50 offer will come anywhere near the 90% tender. If the adjuvant fails the offer may get done.